Evidence map›Paper›PMID 41519705›Full record

ArticleBMC medical imaging2026

A rapid path planning approach for liver tumor ablation with comprehensive constraints.

Kexin Pan, Jun Qin, Guihe Qin

Abstract read
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kexin PanSchool of Computer Science and Technology, Changchun University of Science and Technology, Changchun, 130012, China. 1071464182@qq.com.
Jun QinSchool of Computer Science and Technology, Changchun University of Science and Technology, Changchun, 130012, China. qinjun@cust.edu.cn.
Guihe QinCollege of Computer Science and Technology, Jilin University, Changchun, 130012, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Localized thermal ablation is widely recognized as an effective treatment for liver tumors, offering a minimally invasive alternative to surgical resection. However, the accuracy and safety of the procedure heavily depend on preoperative puncture path planning, which must account for anatomical constraints and potential thermal injury to surrounding tissues. This study proposes an improved multi-objective whale optimization algorithm for preoperative planning of liver tumor ablation. The algorithm simultaneously optimizes the needle trajectory while considering multiple clinical constraints, such as avoiding vital structures and minimizing path length and risk zones. The method was evaluated using real clinical data from seven patients. Experimental results show that the proposed approach achieves an average planning time of 22 s per case, significantly enhancing computational efficiency. Furthermore, it generates two optimized paths for each patient with varying thermal damage zones, both of which outperform existing mainstream optimization algorithms in terms of clinical feasibility and safety. Compared to traditional methods, the proposed algorithm provides faster computation and more reliable path options, better supporting clinical decision-making in liver tumor treatment. These results suggest that the method has strong potential for real-world application in improving the precision and efficiency of thermal ablation procedures.

Indexed as

Ablation TechniquesAlgorithmsCatheter AblationLiver NeoplasmsSurgery, Computer-AssistedHumansTomography, X-Ray ComputedClinical constraintsLiver tumorMulti-objective whale optimization algorithmNeedle trajectoryPreoperative path planning

Identifiers

PMID41519705
PMCPMC12882625

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.